R K Stuart
Overview
Explore the profile of R K Stuart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
571
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Costa L, Abbas J, Hogan K, Kramer C, McDonald K, Butcher C, et al.
Bone Marrow Transplant
. 2012 Apr;
47(11):1403-8.
PMID: 22484324
Lenalidomide is associated with suboptimal autologous hematopoietic stem cell (AHSC) mobilization. We hypothesized that growth factor plus preemptive plerixafor is an effective strategy for AHSC mobilization in multiple myeloma (MM)...
2.
Costa L, Miller A, Alexander E, Hogan K, Shabbir M, Schaub C, et al.
Bone Marrow Transplant
. 2010 Jul;
46(4):523-8.
PMID: 20622909
The ideal method to mobilize autologous hematopoietic stem cells (AHSCs) in patients with lymphoma or multiple myeloma remains to be determined. The use of plerixafor, added to growth factor, may...
3.
Costa L, Alexander E, Hogan K, Schaub C, Fouts T, Stuart R
Bone Marrow Transplant
. 2010 Apr;
46(1):64-9.
PMID: 20383210
Plerixafor is an inhibitor of CXCR-4 (CXC chemokine receptor-4)/SDF (stromal cell-derived factor)-1 binding used in combination with granulocyte colony-stimulating factor (G-CSF) for mobilization of autologous peripheral blood hematopoietic stem cells...
4.
5.
6.
Onitilo A, Lazarchick J, Brunson C, Frei-Lahr D, Stuart R
Transplant Proc
. 2003 Dec;
35(8):3089-92.
PMID: 14697986
As the life expectancy of patients with homozygous sickle cell anemia (SCA) improves, SCA care providers are confronted with diseases of the adult SCA population rarely seen before. We report...
7.
Frankel A, Baer M, Hogge D, Stuart R
Curr Pharm Biotechnol
. 2001 Sep;
2(3):209-15.
PMID: 11530875
Most patients with acute myeloid leukemia (AML) respond initially to combination chemotherapy but later relapse. These patients often die from progressive disease or toxicities of further chemotherapy. At relapse, the...
8.
Ezzat A, Ibrahim E, El Weshi A, Khafaga Y, Aljurf M, Martin J, et al.
Head Neck
. 2001 Jun;
23(7):547-58.
PMID: 11400243
Background: Waldeyer's ring (WR) is the primary site of non-Hodgkin's lymphoma (NHL) involvement in approximately 5% to 10% of all lymphoma patients, and it accounts for more than half of...
9.
High complete pathological response in locally advanced breast cancer using paclitaxel and cisplatin
Ezzat A, Ibrahim E, Ajarim D, Rahal M, Raja M, Stuart R, et al.
Breast Cancer Res Treat
. 2000 Nov;
62(3):237-44.
PMID: 11072788
Background: In an earlier study, we have demonstrated a high response rate in metastatic breast cancer using paclitaxel (P) and cisplatin (C). A phase II study using the same regimen...
10.
Gyger M, Stuart R, Perreault C
Bone Marrow Transplant
. 2000 Aug;
26(1):1-16.
PMID: 10918400
The use of mobilized peripheral blood (PB) stem cells for autologous transplantation initially generated much enthusiasm because of enhanced engraftment in comparison to marrow stem cells and avoidance of general...